Cargando…
Targeting Protein Kinase C for Cancer Therapy
SIMPLE SUMMARY: The protein kinase C (PKC) family belongs to serine-threonine kinases and consists of several subtypes. Increasing evidence suggests that PKCs are critical players in carcinogenesis. Interestingly, PKCs exert both promotive and suppressive effects on tumor cell growth and metastasis,...
Autores principales: | He, Sijia, Li, Qi, Huang, Qian, Cheng, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909172/ https://www.ncbi.nlm.nih.gov/pubmed/35267413 http://dx.doi.org/10.3390/cancers14051104 |
Ejemplares similares
-
Protein Kinase C: An Attractive Target for Cancer Therapy
por: Marengo, Barbara, et al.
Publicado: (2011) -
Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response
por: Aquino, Angelo, et al.
Publicado: (2023) -
RET kinase alterations in targeted cancer therapy
por: Liu, Xuan, et al.
Publicado: (2020) -
Targeting protein kinase A in cancer therapy: an update
por: Sapio, Luigi, et al.
Publicado: (2014) -
Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies
por: Feng, Yuanyuan, et al.
Publicado: (2017)